Prostate Cancer Clinical Trials

A listing of Prostate Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 80 clinical trials
Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer (LuCAB)

This clinical trial will evaluate the safety of Cabazitaxel in combination with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer.

  • 0 views
  • 10 Aug, 2022
  • 1 location
Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load

This phase II trial studies how well durvalumab and olaparib work in treating prostate cancer in men predicted to have specific genetic mutations (a high neoantigen load). Immunotherapy with

androgen suppression
metastasis
hormone therapy
endocrine therapy
androgens
  • 2 views
  • 11 Aug, 2022
  • 1 location
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis

This phase I/II trial studies the best dose and side effects of olaparib and how well it works with radium Ra 223 dichloride in treating patients with castration-resistant prostate cancer that

enzalutamide
luteinizing hormone
bone metastases
orchiectomy
metastatic castration-resistant prostate cancer
  • 92 views
  • 09 Aug, 2022
  • 13 locations
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

) is a safe and effective way to treat previously untreated metastatic prostate cancer, and to see whether the study treatment works better than the standard treatment.

stereotactic body radiation therapy
prednisone
potassium
leuprolide
abiraterone
  • 0 views
  • 08 Aug, 2022
  • 8 locations
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

NUV-868-01 is a first-in-human, open-label, Phase 1/2 dose escalation and expansion study in patients with advanced solid tumors. The Phase 1 and 1b portions include patients with advanced solid tumors and are designed to determine the safety and the dose of NUV-868 to be used as monotherapy and in combination …

taxane
peritoneal cancer
parp inhibitor
systemic chemotherapy
measurable disease
  • 0 views
  • 10 Aug, 2022
  • 4 locations
68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

with prostate cancer and increased PSA after treatment (biochemical recurrence) during androgen deprivation therapy. Diagnostic procedures, such as 68Ga-PSMA-11 PET/CT, may help find and diagnose

  • 0 views
  • 11 Aug, 2022
  • 1 location
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

with castrate-resistant prostate cancer that had spread to other places in the body (metastatic). M3814 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth

enzalutamide
prostate specific antigen
orchiectomy
medical castration
monoclonal antibodies
  • 0 views
  • 10 Aug, 2022
  • 14 locations
A Study to Assess DF6002 (BMS-986415) Alone and in Combination With Nivolumab in Participants With Locally Advanced or Metastatic Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, drug-levels, drug-effects and preliminary anti-tumor activity of DF6002 (BMS-986415) alone and in combination with Nivolumab in participants with advanced solid tumors.

neuropathy
BRAF
progesterone receptor
pembrolizumab
immunosuppressant
  • 22 views
  • 10 Aug, 2022
  • 33 locations
Personalized Precision Diagnosis and Treatment of Pancreatic Cancer (PPDTPC)

the formation and growth of a primary tumor (breast, colon, lung, or prostate cancer, et al.), CTC are released into blood. The published studies on CTCs have focused on their prognostic significance

tumor markers
metastasis
cancer chemotherapy
antineoplastic
  • 0 views
  • 10 Aug, 2022
  • 1 location
A Study of XmAb20717 in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of XmAb20717 in patients with selected advanced gynecologic and genitourinary malignancies.

ovarian epithelial carcinoma
cervical carcinoma
combination therapy
metastasis
fallopian tube
  • 0 views
  • 09 Aug, 2022
  • 2 locations